Valuation: Treace Medical Concepts, Inc.

Market Cap 296M 259M 239M 221M 421M 28.22B 426M 2.86B 1.11B 13.85B 1.11B 1.09B 48.02B P/E 2026 *
-5.07x
P/E 2027 * -5.46x
Enterprise Value 341M 299M 275M 255M 485M 32.52B 491M 3.29B 1.28B 15.96B 1.28B 1.25B 55.34B EV / Sales 2026 *
1.65x
EV / Sales 2027 * 1.73x
Free-Float
74.37%
Yield 2026 *
-
Yield 2027 * -
1 day+8.31%
1 week+6.79%
Current month+14.57%
1 month+29.91%
3 months+216.67%
6 months+56.16%
Current year+86.12%
1 week 3.94
Extreme 3.94
4.62
1 month 3.38
Extreme 3.385
4.78
Current year 1.17
Extreme 1.17
4.78
1 year 1.17
Extreme 1.17
7.78
3 years 1.17
Extreme 1.17
25.22
5 years 1.17
Extreme 1.17
31.76
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 2013-06-30
Director of Finance/CFO 56 2020-08-31
Chief Tech/Sci/R&D Officer - 2022-02-28
Director TitleAgeSince
Chairman 54 2025-05-19
Director/Board Member 64 2020-11-19
Director/Board Member 68 2020-11-19
Date Insider Type Main position Quantity % Market Cap.
06-10Buy

Chief Executive Officer

9,891 0.0152%
06-09Other

Chief Executive Officer

0 0%
05-31Buy

Chief Executive Officer

50,000 0.0771%
Change 5-day change 1-year change 3-year change Capi.($)
+8.31%+6.79%-26.21%-80.45% 296M
-0.11%+0.88%+26.75%-4.03% 12.52B
-0.86%-2.63%+63.97%+35.90% 6.1B
+0.44%+4.44%+8.89%+15.33% 5.81B
-1.92%+2.76% - - 4.29B
-0.09%+1.76%-33.27%+9.48% 4.04B
-0.56%+0.95%-25.83%-23.58% 3.89B
+0.70%+11.89%-2.20%-57.20% 2.01B
-1.09%+4.08%+27.86%+265.83% 1.89B
-0.50%-0.60%+56.01%-6.83% 1.53B
Average +0.43%+4.22%+10.66%+17.16% 4.24B
Weighted average by Cap. -0.33%+2.77%+17.55%+14.67%

Financials

2026 *2027 *
Net sales 206M 181M 166M 154M 293M 19.68B 297M 1.99B 775M 9.66B 775M 758M 33.48B 222M 194M 179M 166M 315M 21.16B 320M 2.14B 834M 10.39B 833M 815M 36.01B
Net income -58.31M -51.06M -47.03M -43.66M -82.9M -5.56B -84.02M -563M -219M -2.73B -219M -214M -9.47B -54.66M -47.87M -44.09M -40.93M -77.72M -5.21B -78.77M -528M -205M -2.56B -205M -201M -8.87B
Net Debt 45.05M 39.46M 36.34M 33.73M 64.06M 4.3B 64.93M 435M 169M 2.11B 169M 165M 7.31B 88.04M 77.11M 71.02M 65.92M 125M 8.4B 127M 850M 331M 4.12B 331M 323M 14.29B
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
26-07-06 US$4.560 +8.31% 662,392
26-07-02 US$4.210 -0.47% 460,661
26-07-01 US$4.230 +6.28% 493,356
26-06-30 US$3.980 -6.79% 1,146,368
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.560USD
Average target price
4.000USD
Spread / Average Target
-12.28%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMCI Stock